Context Therapeutics Inc.
Organization details
- Legal name
- Context Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Philadelphia
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CNTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001842952
- EIN
- 86-3738787
Board of directors
-
Andy Pasternak · DirectorSince 2025
-
Jennifer Evans Stacey · DirectorSince 2023
-
Karen L. Smith · DirectorSince 2024
-
Linda West · DirectorSince 2023
-
Luke Nathaniel Walker · DirectorSince 2024
-
Martin A. Lehr · Director · Chief Executive OfficerSince 2023
-
Philip W. Kantoff · DirectorSince 2023
- Since 2023
Chief executives
Director election results
Annual meeting of June 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.8%
-
99.9%
-
99.9%
-
99.9%
-
100.0%
-
100.0%
-
100.0%
Board connections
3 of this board's directors also sit on 7 other boards. 6 are in the same sector.
-
Aurinia Pharmaceuticals Inc Same sectorvia Karen L. Smith
-
BioVie Inc. Same sectorvia Richard J. Berman
-
Celularity Inc. Same sectorvia Richard J. Berman
-
CryoPort Inc. Same sectorvia Richard J. Berman
- via Richard J. Berman
-
Skye Bioscience Inc. Same sectorvia Karen L. Smith
-
Zentalis Pharmaceuticals Inc. Same sectorvia Luke Nathaniel Walker
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 9, 2025 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +100,000 | $0.70 | $70,000 |
| Jun 6, 2025 | Levit Alex C. Officer (Chief Legal Officer, Corp. Sec) | Open-market purchase | +20,000 | $0.58 | $11,600 |
| Jun 6, 2025 | Minai-Azary Jennifer Lynn Officer (Chief Financial Officer) | Open-market purchase | +40,010 | $0.64 | $25,606 |
| Feb 21, 2023 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +5,823 | $0.84 | $4,891 |
| Feb 13, 2023 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +5,606 | $0.87 | $4,877 |
| Feb 6, 2023 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +5,040 | $0.97 | $4,889 |
| Jan 30, 2023 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +7,027 | $0.70 | $4,919 |
| Jan 23, 2023 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +6,839 | $0.72 | $4,924 |
| Jan 17, 2023 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +6,783 | $0.74 | $5,019 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Context Therapeutics Inc.
Who is the CEO of Context Therapeutics Inc.?
Martin A. Lehr is Context Therapeutics Inc.'s Chief Executive Officer.
How many directors are on Context Therapeutics Inc.'s board?
Context Therapeutics Inc.'s board has 8 directors: Andy Pasternak, Jennifer Evans Stacey, Karen L. Smith, Linda West, Luke Nathaniel Walker, Martin A. Lehr, Philip W. Kantoff and Richard J. Berman.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="context-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.